SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Novo Nordisk Says Wegovy Reduced BMI in Children With Obesity in Phase 3 Trial

Novo Nordisk said Wegovy reduced BMI in children with obesity in a Phase 3 trial.

NVO

Related stories